RecruitingNot ApplicableNCT06566300
Autologous Nanofat Grafting by Injection Versus With Microneedling in Post-burn and Traumatic Atrophic Scars
Sponsor
Alexandria University
Enrollment
30 participants
Start Date
Nov 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the efficiency autologous nanofat injection versus autologous nanofat delivered by microneedling in management of post burn atrophic and traumatic scars.
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Inclusion Criteria1
- \. Males and females between 18-60 years old. 2. Post-burn or traumatic atrophic scar \> 6 months duration (16). 3. Patients not receiving any treatments for the scar within the past 3 months.
Exclusion Criteria3
- \. Patients with contractures, hypertrophic and keloid scars. 2. Patients with history of bleeding disorders or coagulopathy, or on anticoagulant therpy.
- \. Diabetes and other systemic diseases that may be complicated by the procedure.
- \. Pregnant and lactating females. 5. BMI less than 18.5 6. Patients with scars at the donor site
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREinjection of autologous nanofat grafting
Injection of nanfat graft
PROCEDUREmicroneedling with autologus nanofat graft
delivery of nanofat graft with microneedling
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06566300
Related Trials
PMCF Investigation of Medical Device ChitoCare® Medical
NCT068503892 locations
AVAVA MIRIA General Use
NCT068686151 location
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
NCT060212751 location
Treatment of Hypopigmented Scars With Bimatoprost
NCT061220901 location
The use of topical anaesthetic for paediatric pulsed dye laser procedures without a general anaesthetic: a feasibility pilot randomised controlled trial.
ACTRN126230004946391 location